Dermal fibroblast activity slows
When methylation is impaired due to variations in the MTHFR gene , it can contribute to a wide range of health issues, including: Chronic Fatigue Syndrome Fibromyalgia Depression Anxiety ADHD Migraine Headaches High Blood Pressure Infertility Dementia Cancers Autoimmune Diseases Diabetes Obesity Chemical Sensitivities Homocysteine: A Key Marker of Methylation Homocysteine is an important blood marker that reflects methylation efficiency
If you experience persistent side effects such as nausea or vomiting, contact your GP or diabetes specialist nurse for advice on appropriate dose adjustments, slower titration, or alternative treatments
These behavioural wins are the foundations that remain when the medication stops.
GLP-1 cardiovascular outcomes Multiple large-scale cardiovascular outcomes trials have demonstrated that GLP-1 agonists reduce the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death
doi:10.1016/j.lfs.2022.120825